Latest News and Press Releases
Want to stay updated on the latest news?
-
Selskabsmeddelelse19. august 2019 Coloplast – transaktioner i henhold til aktietilbagekøbsprogram Som meddelt i Selskabsmeddelelse nr. 2/2019 har Coloplast iværksat anden del af...
-
NASDAQ Copenhagen 16. August 2019 Report on transactions of executives and related parties in Coloplast shares and related securities ccording to the Market Abuse Regulation article 19 Coloplast...
-
NASDAQ Copenhagen 16. august 2019 Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer I henhold til...
-
NASDAQ Copenhagen14. august 2019 Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer I henhold til...
-
Nasdaq Copenhagen 14 August 2019 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is...
-
In addition to solid organic revenue growth, EBIT increased by 13% to DKK 1,438m, corresponding to an EBIT margin of 31%, in the third quarter of the 2018/19 financial year. The company maintains its...
-
Oven i den solide organiske vækst er driftsresultatet øget med 13% i regnskabsårets tredje kvartal til 1.438 mio. kr., svarende til en overskudsgrad på 31%. Selskabet fastholder sine finansielle...
-
Regnskabsmeddelelse, 9M 2018/19 (1. oktober 2018 - 30. juni 2019) Fortsat solid udvikling i den underliggende forretning i 3. kvartal Coloplast leverede en organisk...
-
Interim financial report, 9M 2018/19(01 October 2018 - 30 June 2019) Solid underlying performance continues in Q3 Coloplast delivered 8% organic growth in the third quarter....
-
Announcement 12 August 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the...